BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 8914388)

  • 21. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Taga S; Ogawa K; Nakagawa T; Tano M
    Kekkaku; 2005 Jan; 80(1):1-7. PubMed ID: 15839056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nontuberculous mycobacteriosis; the present status of epidemiology and clinical studies].
    Sakatani M
    Kekkaku; 1999 Apr; 74(4):377-84. PubMed ID: 10355224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].
    Ogawara M; Sakatani M
    Kekkaku; 1998 Nov; 73(11):673-7. PubMed ID: 9866930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative study of pulmonary disease due to Mycobacterium avium and M. intracellulare identified by a newly developed DNA probe (Gen-Probe].
    Mizutani S
    Kekkaku; 1991 Jan; 66(1):19-38. PubMed ID: 2013966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary infection type atypical mycobacteriosis (lung infection) in the Fuji City Central Hospital during 1989-94].
    Imaizumi T
    Kekkaku; 1997 Jun; 72(6):415-21. PubMed ID: 9248276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
    Yamamoto S; Toida I; Watanabe N; Ura T
    Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of INH and RFP-resistant refractory tuberculosis].
    Kekkaku; 1991 Oct; 66(10):687-706. PubMed ID: 1960917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
    Wada M; Seita A; Mori T; Ogata H; Sugie T; Sugita H
    Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of pulmonary nontuberculous mycobacteriosis].
    Kurashima A
    Kekkaku; 2002 Dec; 77(12):815-21. PubMed ID: 12607341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimycobacterial activities of rifamycin derivatives].
    Kuze F
    Kekkaku; 1991 Oct; 66(10):679-85. PubMed ID: 1960916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
    Sato K; Tomioka H
    Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
    Tsukamura M
    Kekkaku; 1991 May; 66(5):375-80. PubMed ID: 1875580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The short-term effects of multidrug chemotherapy for pulmonary Mycobacterium avium-intracellulare complex (MAC) infection].
    Kurashima A
    Kekkaku; 1998 May; 73(5):371-7. PubMed ID: 9637822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of 41 cases of pulmonary atypical mycobacteriosis].
    Xia XX
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):200-1, 253. PubMed ID: 1307510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.